CDK4 and neoplasm: We found that the concentrations of G1T38 in tumors closely correlated with inhibition of tumor pRB, demonstrating that G1T38 in the tumor could inhibit the CDK4/6/RB pathway and sustain tumor cell growth inhibition after G1T38 plasma concentrations were <1 ng/ml.